Understanding how essential membrane transporters work
Mechanistic studies of essential membrane transporters
This study is looking at how certain proteins in our cells work to move important substances in and out, which could help create new medicines for people with diseases linked to these proteins.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10763764 on NIH RePORTER |
What this research studies
This research investigates the fundamental mechanisms of membrane transporters that are crucial for cellular life and often linked to human diseases. The team aims to explore the structure-function relationships of these transporters, focusing on their substrate selectivity and the development of small molecules that can target them effectively. By employing a multidisciplinary approach that includes biochemistry, microbiology, and molecular dynamics, the research seeks to uncover how these transporters operate and how they can be manipulated for therapeutic purposes. Patients may benefit from the potential development of new drugs targeting these transporters.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to membrane transport dysfunction or those who may benefit from targeted drug therapies.
Not a fit: Patients with conditions unrelated to membrane transporters or those who do not require targeted drug therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new drugs that specifically target membrane transporters, improving treatment options for various diseases.
How similar studies have performed: Previous research has shown promise in understanding membrane proteins and developing targeted therapies, indicating that this approach has potential for success.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Zheng, Hongjin — University of Colorado Denver
- Study coordinator: Zheng, Hongjin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.